跳至主要内容
临床试验/NL-OMON42891
NL-OMON42891已完成不适用

The effect of Aronia melanocarpa administration on cognitive health - The effect of Aronia melanocarpa administration on cognitive health

niversiteit Maastricht0 个研究点目标入组 102 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
102

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • Healthy individuals, age: 40-60 years, BMI 25-35 kg/m2

排除标准

  • - History of severe cardiovascular, respiratory, urogenital, gastrointestinal/hepatic, hematological/immunologic, HEENT (head, ears, eyes, nose, throat). Dermatological/connective tissue, musculoskeletal, metabolic/nutritional, endocrine, neurological diseases, allergy, major surgery and /or laboratory assessments that might limit participation in or completion of the study protocol.
  • - Diabetes
  • - Use of medication that might have influence on endpoints (e.g. hypertension medication)
  • - Administration of investigational drugs or participation in any scientific intervention study which may interfere with this study in the 180 days prior to the study
  • - Use of antibiotics in the 30 days prior to the start of the study
  • - Use of antioxidants, minerals and vitamin supplements available in pharmacies, drugstores, food markets or in alternative medicine
  • - Pregnancy, lactation
  • - Abuse of products (> 20 alcoholic consumptions per week and drugs)
  • - Weight gain or loss (> 3 kg in previous 3 months)
  • - High physical activity (>4.5 hours of running/week)
  • - History of any side effects towards intake of berries

研究者

相似试验